EDAP TMS (EDAP)

• Market cap: $77.9M
• 1 day: 0.00%
• 5 days: -14.63%
• 1 month: -8.30%
• 3 months: -19.85%
• 6 months: -58.08%
• Year to date: -12.50%
• 1 year: -61.11%
• 5 years: -50.59%
• 10 years: -33.96%

About: Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Employees: 307

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

9% more call options, than puts

Call options by funds: $174K | Put options by funds: $159K

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

3% less funds holding

Funds holding: 34 [Q2] → 33 (-1) [Q3]

10.05% less ownership

Funds ownership: 52.08% [Q2] → 42.04% (-10.05%) [Q3]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q2] → 1 (-1) [Q3]

62% less capital invested

Capital invested by funds: $105M [Q2] → $39.8M (-$65.3M) [Q3]